R

Rapid Dose Therapeutics Corp
CNSX:DOSE

Watchlist Manager
Rapid Dose Therapeutics Corp
CNSX:DOSE
Watchlist
Price: 0.145 CAD -6.45% Market Closed
Market Cap: CA$19.4m

Net Margin

-175%
Current
Improving
by 169.3%
vs 3-y average of -344.3%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-175%
=
Net Income
CA$-4.6m
/
Revenue
CA$2.6m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-175%
=
Net Income
CA$-4.6m
/
Revenue
CA$2.6m

Peer Comparison

Country Company Market Cap Net
Margin
CA
Rapid Dose Therapeutics Corp
CNSX:DOSE
19.3m CAD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57B USD
Loading...
US
Dexcom Inc
NASDAQ:DXCM
28.2B USD
Loading...
JP
Terumo Corp
TSE:4543
3.2T JPY
Loading...
US
Insulet Corp
NASDAQ:PODD
18.8B USD
Loading...
US
ABIOMED Inc
LSE:0H7S
17.2B USD
Loading...
US
Zimmer Biomet Holdings Inc
NYSE:ZBH
17.1B USD
Loading...
US
West Pharmaceutical Services Inc
NYSE:WST
17.3B USD
Loading...
US
Penumbra Inc
NYSE:PEN
14.1B USD
Loading...
NZ
Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
22.7B NZD
Loading...
US
Shockwave Medical Inc
F:36M
11.3B EUR
Loading...

Market Distribution

Lower than 76% of companies in Canada
Percentile
24th
Based on 4 909 companies
24th percentile
-175%
Low
-9 940 586.9% — -85.9%
Typical Range
-85.9% — 5.5%
High
5.5% — 60 777.6%
Distribution Statistics
Canada
Min -9 940 586.9%
30th Percentile -85.9%
Median -7.8%
70th Percentile 5.5%
Max 60 777.6%

Rapid Dose Therapeutics Corp
Glance View

Market Cap
19.4m CAD
Industry
N/A

Rapid Dose Therapeutics Corp. engages in the provision of proprietary drug delivery technologies. The company is headquartered in Burlington, Ontario. The company went IPO on 2018-12-17. The firm provides drug-delivery technologies. The firm also provides production and consultation to the nutraceutical, cannabis healthcare and pharmaceutical manufacturing industries. The company owns an oral fast-dissolving drug delivery system, QuickStrip, which is capable of releasing into the blood stream a list of pharmaceuticals, emulsified oils and over-the-counter medicines without being degraded or modified by first pass metabolism in the liver. Its QuickStrip Energy product delivers energizing caffeine. Its QuickStrip B12 product delivers vitamin B12 to user's system, assisting with metabolism and physical energy. Melatonin is its QuickStrip Sleep product that delivers melatonin to the user's system. The RDMx mixture is its formulation, which is processed using RDT production equipment.

DOSE Intrinsic Value
Not Available
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-175%
=
Net Income
CA$-4.6m
/
Revenue
CA$2.6m
What is Rapid Dose Therapeutics Corp's current Net Margin?

The current Net Margin for Rapid Dose Therapeutics Corp is -175%, which is above its 3-year median of -344.3%.

How has Net Margin changed over time?

Over the last 3 years, Rapid Dose Therapeutics Corp’s Net Margin has increased from -415.6% to -175%. During this period, it reached a low of -520.2% on May 31, 2024 and a high of -175% on Oct 1, 2025.

Back to Top